Consensus Ashland Inc.

Stocks

ASH

US0441861046

Diversified Chemicals

Real-time Estimate Cboe BZX 14:06:14 2026-10-01 EDT			5-day change	1st Jan Change
68.03 ^USD	+0.16%		-1.01%	+16.58%

09-17	Ashland Inc. - Analyst/Investor Day
08-24	Ashland Inc. Launches Permexa Sodium Caprate to Support Scalable Development and Commercialization of Oral Peptide, Biologic and Low-Permeability Drug Products	CI

Evolution of the Average Target: Ashland Inc.

Evolution of the Target Price: Ashland Inc.

Changes in Analyst Recommendations: Ashland Inc.

f097110.ZvMyLFTuwJowf4wE62I4v4YNFVpKGFdkMfrUI7SyeYs.DIFbYw2GlPhJKuM9klVX6MtfTTgtThNWerWce8KGDuZXlgtaO6GEyAMV7w~7fac0aae743452cda0b93f01840a7542

Analysts' recommendations: Ashland Inc.

08-06	Ashland's Fundamentals Appear to Improve With a Fiscal Q3 Beat, Morgan Stanley Says	MT
08-06	Morgan Stanley Adjusts Price Target on Ashland to $78 From $58, Maintains Equalweight Rating	MT
07-31	Deutsche Bank Adjusts Ashland Price Target to $85 From $74, Maintains Buy Rating	MT
07-30	UBS Adjusts Price Target on Ashland to $83 From $75, Maintains Buy Rating	MT
06-15	Deutsche Bank Adjusts Ashland Price Target to $74 From $60, Maintains Buy Rating	MT
06-10	UBS Lifts Ashland Price Target to $72 From $66, Maintains Buy Rating	MT
05-06	Seaport Upgrades Ashland to Buy From Neutral, Sets $75 Price Target	MT
05-04	Ashland's Fiscal Q2 a 'Mixed Bag' With Downward EBITDA Revisions, Morgan Stanley Says	MT
05-04	Morgan Stanley Lowers Price Target on Ashland to $58 From $63, Keeps Equalweight Rating	MT
04-06	Mizuho Cuts Price Target on Ashland to $65 From $70, Keeps Outperform Rating	MT
02-04	UBS Adjusts Price Target on Ashland to $73 From $70, Maintains Buy Rating	MT
02-04	Deutsche Bank Adjusts Ashland Price Target to $70 From $58, Maintains Buy Rating	MT
01-12	UBS Adjusts Price Target on Ashland to $70 From $64, Maintains Buy Rating	MT
12-18	Mizuho Securities Adjusts Ashland Price Target to $70 From $60, Maintains Outperform Rating	MT
12-15	Ashland Shares Rise After BMO Capital Upgrade	MT
12-15	BMO Capital Upgrades Ashland to Outperform From Market Perform, Adjusts PT to $71 From $61	MT
11-12	Deutsche Bank Raises Price Target on Ashland to $58 From $55, Keeps Buy Rating	MT
25-10-03	Mizuho Lowers Price Target on Ashland to $54 From $58, Keeps Outperform Rating	MT
25-09-30	Deutsche Bank Cuts Price Target on Ashland to $55 From $62, Keeps Buy Rating	MT
25-09-08	Morgan Stanley Initiates Coverage on Ashland With Equal Weight Rating, $60 Price Target	MT
25-08-07	UBS Adjusts Price Target on Ashland to $64 From $73, Maintains Buy Rating	MT
25-07-09	UBS Trims Price Target on Ashland to $73 From $74, Maintains Buy Rating	MT
25-05-02	Wells Fargo Downgrades Ashland to Equalweight From Overweight, Adjusts Price Target to $50 From $58	MT
25-05-01	UBS Adjusts Price Target on Ashland to $74 From $85, Maintains Buy Rating	MT
25-03-26	JPMorgan Upgrades Ashland to Overweight From Neutral, Adjusts Price Target to $71 From $68	MT

More recommendations

Diversified Chemicals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ASHLAND INC.					+18.05%
	SHIN-ETSU CHEMICAL CO., LTD.					+30.58%
	BASF SE					+4.57%
	PIDILITE INDUSTRIES LIMITED					+21.76%
	ASAHI KASEI CORPORATION					+18.05%
	MITSUBISHI CHEMICAL GROUP CORPORATION					+10.81%
	BRENNTAG SE					-2.44%
	SYENSQO SA/NV					+5.57%
	SASOL LIMITED					-8.11%
	SRF LIMITED					+17.93%
	Average					+11.68%
	Weighted average by Cap.					+16.33%